AIMEE DIAZ: Open Payments
NPI 1992224794 · TAMARAC, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 18 payments from 8 companies in 2025. Trend: 2023 $380 · 2024 $349 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $136 |
| Sumitomo Pharma America, Inc. | 4 | $86 |
| PFIZER INC. | 3 | $60 |
| Amgen Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Eisai Inc. | 2 | $36 |
| Boston Scientific Corporation | 1 | $30 |
| Lilly USA, LLC | 1 | $17 |
Products named: Ozempic, GEMTESA, ELIQUIS, Leqembi, BodyGuardian, KRYSTEXXA, FARXIGA, REPATHA.
Industry payments across FL — which companies pay providers there.
